Neuropathic pain is a complex and often debilitating condition that arises from damage to the nervous system. Understanding the mechanisms behind neuropathic pain is crucial for developing ...

综上所述，对神经病理性疼痛的评估和管理需要一个综合的方法，包括全面的临床评估、症状分析和量表评估。随着研究的不断深入，我们相信将会有更多更精确的评估工具出现，帮助医生更好地了解和处理这一复杂的病症。

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.

A dysfunctional signaling pathway in the hippocampus has been linked to chronic pain-related memory impairment in mice.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...